97 / 119
96
Diretrizes AMB
3.
Strober BE, Crowley JJ, Yamauchi PS, Olds M, Williams DA. Efficacy and
safety results from a phase III, randomized controlled trial comparing
the safety and efficacy of briakinumab with etanercept and placebo in
patients with moderate to severe chronic plaque psoriasis. Br J Dermatol.
2011 Sep;165(3):661-8. PubMed PMID: 21574984.
4.
Gottlieb AB, Leonardi C, Kerdel F, Mehlis S, Olds M, Williams DA.
Efficacy and safety of briakinumab vs. etanercept and placebo in patients
with moderate to severe chronic plaque psoriasis. Br J Dermatol. 2011
Sep;165(3):652-60. PubMed PMID: 21574983.